The Insight Partners Latest Research for Report “Epinephrine Market to 2027″ Focuses Global Analysis and Forecasts By Product Type (Prefilled Syringes, Auto-Injectors, Ampoules and Vials); Application (Anaphylaxis, Superficial Bleeding, Respiratory Disorders, Cardiac Arrest); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) and Geography
Epinephrine Market to 2027 is anticipated to reach US$ 4,207.88 Mn by 2027 from US$ 2,247.87 Mn in 2019. The market is anticipated to grow with a CAGR of 8.3% from 2020-2027. The report provides trends prevailing in the global epinephrine market and the factors driving the market along with those that act as hindrances.
Download PDF Sample Copy at:
The epinephrine market is highly competitive, with a considerable number of players operating in the market. Most of the companies operating in the epinephrine market are present across the globe and have wide distribution and sales networks through partnerships or authorized dealers.
The most notable market participants are MYLAN N.V., Abbott, ALK ABELLO, Amneal Pharma, Kaleo, LINCOLN MEDICAL LTD (BioProject), Teva Pharmaceuticals Ltd, Adamis Pharmaceuticals Corporation (Novartis AG), Emirade, and Aurum Pharma (Ethypharm Group Company), among others occupying a considerable share of the market owing to their offerings to the market.
Market leaders are involved in various organic and inorganic strategies to strengthen their business and market growth. The companies have utilized organic strategies such as product launches, expansion, investments among other strategies and some inorganic strategies such as acquisition, agreement and partnerships & collaborations which have promoted its growth.
Few of the essential vital developments from the industry are mentioned below:
July, 2019: Sandoz Inc., a Novartis AG division launched SYMJEPI autoinjectors in US market.
August, 2019: The Alk-Abelló A/S announced strategic distribution partnership with an US based company Windgap Medical. The strategic partnership is formed to commercialize ALK’s epinephrine autoinjectors in US market
August, 2018: The Kaleo Inc. announced sufficient availability of AUVI-Q epinephrine autoinjectors in the US market. Kaleo confirmed that the supply of the product will not be hampered due to manufacturing delays, also the company is capable to serve anticipated demand in the U.S
Have a Call with Analyst:
January, 2017: Erythpharm acquired Martindale Pharma, a UK based player which operates in manufacturing and distribution of products for opioid addiction, emergency care and sterile Injectable.
Epinephrine is a medication used along with emergency medical treatment services for the allergic reactions caused by insect bites or stings, foods, drugs and latex, among others. It works by relaxing the muscles in the airways and tightening the blood vessels. The injection is available as a prefilled automatic injection device that contains the solution and in vials to inject subcutaneously and others. The injection is generally injected as required at the first sign of a severe allergic reaction.
In terms of product type, the Epinephrine market is segmented into prefilled syringes, auto-injectors, ampoules and vials. The auto-injectors segment held the largest share of the market in 2019. The auto-injectors segment is also anticipated to register the highest CAGR of 8.6% in the market during the forecast period.
Based on application, the Epinephrine market is segmented into anaphylaxis, superficial bleeding, respiratory disorders, cardiac arrest. The anaphylaxis segment held the largest share of the market in 2019. Anaphylaxis segment is also estimated to register the highest CAGR of 8.9% in the market during the forecast period.
Buy Report at:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi